Instil Bio, Inc.
TIL
$16.00
$0.5453.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.33% | -54.33% | 38.62% | -88.02% | 80.83% |
| Total Depreciation and Amortization | -17.76% | -7.59% | -1.81% | -4.15% | 8.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.74% | 159.94% | -38.66% | 1,709.30% | -100.87% |
| Change in Net Operating Assets | 56.33% | -811.83% | -156.21% | 273.17% | -185.45% |
| Cash from Operations | 47.55% | -89.72% | 26.26% | -7.56% | 7.24% |
| Capital Expenditure | -- | -- | -- | -- | 98.88% |
| Sale of Property, Plant, and Equipment | 6,300.00% | -99.08% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.99% | 74.13% | 23.08% | -25.76% | 66.52% |
| Cash from Investing | -34.39% | 66.27% | 28.93% | -33.74% | 501.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 29.56% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 903.77% | -- | -- | -- | 100.00% |
| Foreign Exchange rate Adjustments | -254.76% | 625.00% | 87.30% | -231.58% | 77.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,466.10% | -109.10% | 124.88% | -1,047.64% | 104.30% |